Skip Navigation



Annals of Oncology Advance Access published online on April 25, 2008
Annals of Oncology, doi:10.1093/annonc/mdn175
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/6/1207    most recent
mdn175v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lacalamita, R.
Right arrow Articles by Paradiso, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacalamita, R.
Right arrow Articles by Paradiso, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

ISO 9001:2000 applied to a research oncology laboratory: which problems? The experience of National Cancer Institute-Bari

The first 10% of the full text of this article appears below.

Quality assurance of health care services has become a crucial issue in the last years.

Compliance with UNI EN ISO 9001:2000 standard was adopted by many oncology institutes worldwide, with the aim to provide high-quality patient-focused performances [1].

Here we provide a description of implementation of a Quality Management Systems carried out in the Clinical and Experimental Oncology Laboratory (CEOL) of the National Cancer Institute of Bari, drawing attention to critical points of ‘Certification Process’ in a research laboratory where procedures and results are rapidly changing and hardly standardizable.

The whole process . . . [Full Text of this Article]

R. Lacalamita1,*, M. Schirone2 and A. Paradiso1

1 Clinical Experimental Oncology Laboratory, National Cancer Institute Giovanni Paolo II
2 TQM Consult S.p.A., Bari, Italy

* (E-mail: r.lacalamita@oncologico.bari.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?